PH+ ALL

Clinical trials for PH+ ALL explained in plain language.

Never miss a new study

Get alerted when new PH+ ALL trials appear

Sign up with your email to follow new studies for PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New combo therapy aims to tame aggressive leukemia with less toxicity

Disease control Recruiting now

This study tests a new treatment for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), a fast-growing blood cancer. It combines low-intensity chemotherapy with targeted drugs (venetoclax, blinatumomab, and olverembatinib) to impr…

Matched conditions: PH+ ALL

Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 22, 2026 14:03 UTC

PH+ ALL

Get alerted when new PH+ ALL trials appear

New combo therapy aims to tame aggressive leukemia with less toxicity